Vernalis (R&D) Ltd.
A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2016-05-06
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 6
- Registration Number
- NCT02764892
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT02253745
- Locations
- 🇺🇸
Vince and Associates Clinical Research, Kansas City, Kansas, United States
Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2012-07-11
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT01634529
- Locations
- 🇬🇧
Hammersmith Medicines Research Limited, London, United Kingdom
A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 49
- Registration Number
- NCT01634568
- Locations
- 🇬🇧
Hammersmith Medicines Research, London, United Kingdom
Phase II Open-Label Pilot Study of V3381 in Chronic Cough
- Conditions
- Cough
- First Posted Date
- 2011-07-25
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT01401673
- Locations
- 🇬🇧
South Manchester University Hospital, Manchester, United Kingdom
Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 161
- Registration Number
- NCT00794430
- Locations
- 🇨🇿
Nemocnice Ceske Budejovice, Ceske Budejovice, Czech Republic
🇬🇧Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom
🇨🇿Neurologicke oddeleni, Pardubice, Czech Republic
Safety and Efficacy of Low Doses of V24343 in Obese Subjects
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 32
- Registration Number
- NCT00734201
- Locations
- 🇬🇧
Hammersmith Medicines Research, London, United Kingdom
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 27
- Registration Number
- NCT00491998
- Locations
- 🇮🇹
IRCCS San Raffaele Pisana, Roma, Rome, Italy
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
- Conditions
- PainDiabetic Neuropathies
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2007-04-02
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT00375960
- Locations
- 🇨🇦
LMC Endocrinology Centres Ltd., Thornhill, Ontario, Canada
🇺🇸Diablo Clinical Research, Inc., Walnut Creek, California, United States
🇺🇸Clinical Research of West Florida, Inc., Clearwater, Florida, United States
Safety and Efficacy Study in Acute Ischaemic Stroke
- Conditions
- Stroke
- Interventions
- Drug: V10153
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- Vernalis (R&D) Ltd
- Target Recruit Count
- 49
- Registration Number
- NCT00144014
- Locations
- 🇺🇸
Tallahassee Memorial Hospital, Tallahassee, Florida, United States
🇺🇸UMAS Memorial Medical Centre, Worcester, Massachusetts, United States
🇺🇸UCLA Stroke Network, Los Angeles, California, United States